Mentzer RM et al. |
Tacrolimus as a rescue immunosuppressant after heart and lung transplantation. The U.S. Multicenter FK506 Study Group. |
1998 |
Transplantation |
pmid:9448154
|
Busuttil RW and Lake JR |
Role of tacrolimus in the evolution of liver transplantation. |
2004 |
Transplantation |
pmid:15201686
|
Vincenti F |
A decade of progress in kidney transplantation. |
2004 |
Transplantation |
pmid:15201687
|
Pascual J et al. |
Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant. |
2006 |
Transplantation |
pmid:16861942
|
Bunnapradist S et al. |
Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids. |
2003 |
Transplantation |
pmid:12865780
|
Asberg A et al. |
Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients. |
2006 |
Transplantation |
pmid:16861943
|
Pfitzmann R et al. |
Mycophenolatemofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients. |
2003 |
Transplantation |
pmid:12865798
|
Briggs D et al. |
Effects of immediate switch from cyclosporine microemulsion to tacrolimus at first acute rejection in renal allograft recipients. |
2003 |
Transplantation |
pmid:12829912
|
Chaftari AM et al. |
Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation. |
2012 |
Transplantation |
pmid:22814329
|
Selzner N et al. |
Conversion from cyclosporine to FK506 in adult liver transplant recipients: a combined North American and European experience. |
2001 |
Transplantation |
pmid:11579301
|
Savoldo B et al. |
Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients. |
2001 |
Transplantation |
pmid:11579304
|
Fisher NC et al. |
Chronic renal failure following liver transplantation: a retrospective analysis. |
1998 |
Transplantation |
pmid:9679823
|
Sanchez-Campos S et al. |
Cholestasis and alterations of glutathione metabolism induced by tacrolimus (FK506) in the rat. |
1998 |
Transplantation |
pmid:9679826
|
Shao X et al. |
Tacrolimus-associated ischemic optic neuropathy and posterior reversible encephalopathy syndrome after small bowel transplantation. |
2012 |
Transplantation |
pmid:23128973
|
Newell KA et al. |
Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice. |
1997 |
Transplantation |
pmid:9381541
|
Iyengar AR et al. |
Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus. |
1997 |
Transplantation |
pmid:9158008
|
Størset E et al. |
Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study. |
2015 |
Transplantation |
pmid:25886918
|
Platz KP et al. |
Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. |
1994 |
Transplantation |
pmid:7518975
|
Carroll PB et al. |
Effect of the immunosuppressant FK506 on glucose-induced insulin secretion from adult rat islets of Langerhans. |
1991 |
Transplantation |
pmid:1702911
|
Burroughs TE et al. |
Increasing incidence of new-onset diabetes after transplant among pediatric renal transplant patients. |
2009 |
Transplantation |
pmid:19667939
|
Mittal SK et al. |
Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors. |
2009 |
Transplantation |
pmid:19667950
|
Kihm LP et al. |
Acute effects of calcineurin inhibitors on kidney allograft microperfusion visualized by contrast-enhanced sonography. |
2012 |
Transplantation |
pmid:22470107
|
Hoogtanders K et al. |
Dried blood spot measurement of tacrolimus is promising for patient monitoring. |
2007 |
Transplantation |
pmid:17264824
|
Xie Y et al. |
Delayed Donor Bone Marrow Infusion Induces Liver Transplant Tolerance. |
2017 |
Transplantation |
pmid:28187014
|
Hooper DK et al. |
Risk of tacrolimus toxicity in CYP3A5 nonexpressors treated with intravenous nicardipine after kidney transplantation. |
2012 |
Transplantation |
pmid:22491658
|
Sarwal MM et al. |
Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. |
2003 |
Transplantation |
pmid:14627912
|
Vignali D et al. |
IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody. |
2016 |
Transplantation |
pmid:27306531
|
Homma M et al. |
Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation. |
2002 |
Transplantation |
pmid:11821750
|
Chakrabarti P et al. |
Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. |
2000 |
Transplantation |
pmid:11003353
|
Inoue T et al. |
Lesser reduction in bone mineral density by the immunosuppressant, FK506, compared with cyclosporine in rats. |
2000 |
Transplantation |
pmid:11003356
|
Iwata H et al. |
Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK506. |
1993 |
Transplantation |
pmid:7687396
|
Shapiro R et al. |
"Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression. |
1996 |
Transplantation |
pmid:8932264
|
de Fijter JW |
Tacrolimus dosing in mycophenolate-treated patients--can we get away with less? |
2011 |
Transplantation |
pmid:21654351
|
Nankivell BJ et al. |
Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras. |
2016 |
Transplantation |
pmid:27306529
|
Ochiai T et al. |
Studies of the effects of FK506 on renal allografting in the beagle dog. |
1987 |
Transplantation |
pmid:2447688
|
De Ruvo N et al. |
Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation. |
2005 |
Transplantation |
pmid:16003226
|
Reich DJ et al. |
Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: randomized, prospective, multicenter pilot study results. |
2005 |
Transplantation |
pmid:16003228
|
Paterson DL et al. |
Infectious complications occurring in liver transplant recipients receiving mycophenolate mofetil. |
1998 |
Transplantation |
pmid:9753337
|
Guthery SL et al. |
Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment. |
2003 |
Transplantation |
pmid:12698085
|
Guasch A et al. |
Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy. |
2010 |
Transplantation |
pmid:20811320
|
Wennberg L et al. |
Preapheresis immunosuppressive induction: necessary or harmful? |
2007 |
Transplantation |
pmid:18162987
|
Ciancio G et al. |
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year. |
2004 |
Transplantation |
pmid:14742990
|
Azzola A et al. |
Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation. |
2004 |
Transplantation |
pmid:14742993
|
Bendahan J et al. |
The effect of administration of FK506 on delayed regeneration in flushed partially hepatectomized livers. |
1994 |
Transplantation |
pmid:7511255
|
Chavin KD et al. |
Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance. |
1994 |
Transplantation |
pmid:7511258
|
Hoerning A et al. |
Pharmacodynamic monitoring of mammalian target of rapamycin inhibition by phosphoflow cytometric determination of p70S6 kinase activity. |
2015 |
Transplantation |
pmid:25099702
|
Ricordi C et al. |
In vivo effect of FK506 on human pancreatic islets. |
1991 |
Transplantation |
pmid:1716797
|
Yilmaz MI et al. |
Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation. |
2005 |
Transplantation |
pmid:16378057
|
Zhang W et al. |
Isoglycyrrhizinate Magnesium Enhances Hepatoprotective Effect of FK506 on Ischemia-Reperfusion Injury Through HMGB1 Inhibition in a Rat Model of Liver Transplantation. |
2017 |
Transplantation |
pmid:28885495
|
Guitard J et al. |
Predictive factors for anemia six and twelve months after orthotopic liver transplantation. |
2006 |
Transplantation |
pmid:16770241
|